|
|
|
|
|
|
|
|
|
|
|
05.05.26 - 15:03
|
Zifo′s SiEE Boston Summit Charts New Roadmap for ′Practical AI′ in Life Sciences, Bridging the Gap Between Business Vision and Lab Reality (PR Newswire)
|
|
|
BOSTON, May 5, 2026 /PRNewswire/ -- Trading the abstract allure of AI hype for a technical implementation roadmap, Zifo's 2026 Scientific Informatics Experience Exchange (SiEE) in Boston concluded with heavyweights from Sanofi, Takeda, AbbVie, Regeneron, Biogen, Eli Lilly, Novo Nordisk,......
|
|
|
05.05.26 - 12:42
|
Jeito Capital Bolsters Its Leadership Team With the Appointment of Elaine Caughey, MBA, as Partner, Business Development and Investor Relations, and Sarah Shackelton, MPA, as Partner, Talent (Business Wire)
|
|
|
Highly experienced partners bringing 25+ years of leadership across top-tier life-sciences investment fund, pharma and Biopharma companies, driving accelerated portfolio development
With leadership experience at Blackstone Life Sciences (Deputy Chief Operating Officer), Biogen, (NASDAQ: BIIB), and public and private Biopharma companies (including Kymera Therapeutics (NASDAQ: KYMR) and Cygnal Therapeutics), Elaine Caughey will support portfolio companies in strengthening operational execution, defining robust market access pathways, and enhancing their strategic value through business development support, including partnerships and acquisition transactions. She will also draw on her knowledge of the investment ecosystem to strengthen relationships with investors for both Jeito funds and its portfolio companies
Sarah brings deep strategic expertise from senior roles at leading Biopharma investment firms - including as Partner, Marketing and Talent at Abingworth and as Chief Talent Officer at Oxford Science ...
|
|
|
04.05.26 - 14:06
|
Spruce Biosciences Further Strengthens its Commercial Leadership Team with the Appointments of Brian Walls as Vice President, Market Access and Darren Johnson as Vice President, Commercial Operations (Business Wire)
|
|
|
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced the appointments of Brian Walls as Vice President, Market Access and Darren M. Johnson as Vice President, Commercial Operations.
Mr. Walls brings more than 20 years of biopharmaceutical commercial leadership experience and has contributed to more than 18 product launches across rare, ultra-rare, oncology, neurology, and metabolic disorders. Most recently, he served as Vice President, Market Access at Applied Therapeutics, Inc. (acquired by Cycle Pharmaceuticals), where he architected the U.S. commercialization access platform for ultra-rare neurology assets. Prior to Applied Therapeutics, he served as Vice President, Market Access at Reata Pharmaceuticals (acquired by Biogen), leading enterprise access strategy for the launch of SKYCLARYS. Earlie...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
29.04.26 - 13:48
|
Biogen Updates 2026 Guidance (AFX)
|
|
|
WESTON (dpa-AFX) - Biogen (BIIB) said, for 2026, it now expects adjusted EPS in a range of $14.25 to $15.25, revised from prior guidance range of $15.25 to $16.25. Biogen updated its guidance to r......
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
